Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
89 studies found for:    Open Studies | "Adverse Drug Events" OR "Adverse Drug Reactions" OR "Drug Related Side Effects"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Adverse Drug Events" OR "Adverse Drug Reactions" OR "Drug Related Side Effects"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years
Conditions: Adverse Drug Events;   Adverse Drug Reactions
Intervention: Drug: Qingkailing Injection
2 Not yet recruiting Information Systems-enabled Outreach Program for Adverse Drug Events
Condition: Adverse Drug Events
Intervention: Other: ISTOP-ADE
3 Recruiting National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children
Condition: Adverse Drug Reaction (ADR)
Intervention:
4 Recruiting Clinical Trial of a New Software ENgine for the Assessment & Optimization of Drug and Non-drug Therapy in Older peRsons
Condition: Adverse Drug Reactions
Intervention:
5 Recruiting YouScript IMPACT Registry
Conditions: Adverse Drug Events;   Adverse Drug Reactions;   Drug Interaction Potentiation;   Drug Metabolism, Poor, CYP2D6-RELATED;   Drug Metabolism, Poor, CYP2C19-RELATED;   Cytochrome P450 Enzyme Deficiency;   Cytochrome P450 CYP2D6 Enzyme Deficiency;   Cytochrome P450 CYP2C9 Enzyme Deficiency;   Cytochrome P450 CYP2C19 Enzyme Deficiency;   Cytochrome P450 CYP3A Enzyme Deficiency;   Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant;   Poor Metabolizer Due to Cytochrome P450 CYP2C19 Variant;   Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant
Intervention:
6 Recruiting Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study
Conditions: Safety Surveillance;   Adverse Drug Events;   Adverse Drug Reactions;   Severe Adverse Events;   Severe Adverse Reactions
Intervention: Drug: Compound Kuh-seng Injection
7 Recruiting Pharmacogenetic Testing Among Home Health Patients
Conditions: Adverse Drug Events;   Adverse Drug Reactions;   Drug Interaction Potentiation;   Drug Metabolism, Poor, CYP2D6-RELATED;   Drug Metabolism, Poor, CYP2C19-RELATED;   Cytochrome P450 Enzyme Deficiency;   Cytochrome P450 CYP2D6 Enzyme Deficiency;   Cytochrome P450 CYP2C9 Enzyme Deficiency;   Cytochrome P450 CYP2C19 Enzyme Deficiency;   Cytochrome P450 CYP3A Enzyme Deficiency;   Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant;   Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant;   Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant
Intervention: Genetic: Pharmacogenetic testing
8 Recruiting Using Novel Canadian Resources to Improve Medication Reconciliation at Discharge
Conditions: Medication Reconciliation;   Adverse Drug Events
Intervention: Other: Electronic Medication Reconciliation
9 Recruiting Multi-Center Medication Reconciliation Quality Improvement Study
Conditions: Adverse Drug Events;   Medication Administered in Error
Intervention: Other: Mentored medication reconciliation quality improvement
10 Recruiting the Pharmacy Intervention Team Hospital-based (PITH) for People Study: Effect on Clinical and Economic Outcomes
Conditions: Adverse Drug Reaction;   Medication Administered in Error
Intervention: Other: integrated medicines management
11 Recruiting Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
Conditions: Adverse Drug Reaction;   Cinepazide;   Stroke
Intervention:
12 Recruiting The Drug Induced Renal Injury Consortium
Conditions: Acute Kidney Injury;   Adverse Drug Reaction;   Acute Kidney Failure;   Kidney Failure;   Kidney Disease
Intervention:
13 Recruiting Diagnosing Adverse Drug Reactions Registry
Condition: Genetics of Drug Metabolism
Intervention:
14 Recruiting MARY D&Apos;UOL REPAIR BALM IN THE PREVENTION OF SKIN TOXICITY BY CAPECITABINE
Condition: Dermatitis, Adverse Drug Reaction
Interventions: Procedure: BALM ARM;   Procedure: PLACEBO ARM
15 Unknown  Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions
Condition: Drug Hypersensitivity
Intervention: Drug: anti-TNF a
16 Not yet recruiting Pharmacogenomics Registry to Assess Clinical Utility
Condition: Drug Side Effects
Intervention:
17 Recruiting The Effect of a Pharmacist Home Visit on Drug-related Problems Post-discharge.
Conditions: Adverse Drug Event;   Readmission;   Patient Compliance
Intervention: Behavioral: HomeCoMe-program
18 Recruiting Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients
Conditions: Self Efficacy;   Adverse Drug Event;   Carcinoma, Renal Cell
Intervention: Drug: pazopanib
19 Unknown  Study Comparing Conventional and Fast Track Multi-Discipline Treatment Interventions for Colorectal Cancer
Conditions: Length of Stay;   Complications;   Adverse Drug Event;   Quality of Life;   Hospital Costs
Interventions: Procedure: Laparoscopic Surgery for Colorectal Cancer;   Drug: XELOX Chemotherapy;   Drug: mFolfox6 chemotherapy;   Other: Fast Track Perioperative Treatment;   Other: Conventional Perioperative Treatment;   Procedure: Open Surgery for Colorectal Cancer
20 Recruiting How Safe Are Our Pediatric Emergency Departments?
Conditions: Adverse Effects;   Adverse Drug Event
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years